Critically analyzing clinical data: post-hoc analysis of aducanumab

Why to do Ad-hoc Reporting when you can Build Data Driven Apps?

Kentik Ad hoc Data Analysis with Jim Meehan

NISS-Merck Virtual Meet-up: "Estimands and Sensitivity Analysis in Clinical Trials" January, 2018

Sharing Clinical Trial Data: Soliciting your thoughts on IOM Framework Report

A post-hoc analysis of LipidiDiet: ADCOMS, GST & BHA

Reader beware: Interpreting post hoc analyses

"Policy on a Page: Operational Workflow for Ad-Hoc Analyses" by Aaron Burgess

Analyzing FDA's statistical review of a Phase 3 program

Estimands in Oncology - A Virtual Panel Discussion

Ad hoc behavioral analysis in a situation. The hot key infos!

Dr. Daniel Gillen - How Clinical Trials Work

What are Clinical Trials? with Richard Goldberg, MD

Authoring Efficiencies and Cross-functional Strategies: Clinical Study Report and Beyond

NISS-Merck Meet-up: "Multiple Endpoints in Clinical Trials" September, 2017

Interim analysis of a prospective, randomized phase II trial of trastuzumab vs trastuzumab + E75

NACFC 2022 | W21: Evidence-Based Medicine: Update on Clinical Trials in Cystic Fibrosis

Joint webinar on estimands in clinical trials (Nov 5, 2020)

[Webinar] E9(R1) Addendum on Estimands: The Use of Estimand Framework for Oncology Clinical Trials

"Design and Statistical Considerations for Clinical Trials"